Evaluation of the patients with Diabetes Mellitus admitted to intensive care unit with the diagnosis of COVID-19
Abstract
Background: Diabetes mellitus (DM) is a common comorbidity among patients with coronavirus disease 2019 (COVID-19) and has been associated with severe disease and adverse clinical outcomes. This study aimed to evaluate demographic characteristics, comorbidities, laboratory findings, microbiological culture results, and treatment-related factors in critically ill patients with COVID-19 and DM and to compare these findings between survivors and non-survivors. Materials and Methods: This retrospective observational study included adult patients with confirmed COVID-19 and DM who were admitted to the intensive care unit (ICU) between March 2020 and March 2022. Demographic characteristics, comorbidities, steroid treatment, laboratory parameters at ICU admission, microbiological culture results, and development of acute kidney injury (AKI) were retrospectively evaluated. Patients were classified as survivors or non-survivors according to ICU outcome. Results: A total of 112 patients were included; 31 (27.7%) survived and 81 (72.3%) died during ICU follow-up. The mean age was 68.7 ± 11.6 years, and 47.3% were female. Age and sex did not differ significantly between survivors and non-survivors. Chronic obstructive pulmonary disease was more frequent among survivors than non-survivors (29.0% vs. 4.9%, p<0.001), whereas pulse steroid therapy was more frequently administered to non-survivors (27.2% vs. 9.7%, p=0.047). At ICU admission, neutrophil count, procalcitonin, and lactate dehydrogenase levels were significantly higher in non-survivors (p=0.014, p=0.025, and p=0.027, respectively). Positive blood cultures and tracheal aspirate cultures were detected in 45.5% and 17.9% of patients, respectively, and AKI developed in 40.2%. Conclusion: Mortality was high among critically ill patients with COVID-19 and DM. Higher neutrophil count, procalcitonin, and lactate dehydrogenase levels at ICU admission were associated with mortality. The high frequencies of AKI and infection-related findings further demonstrate the substantial burden of organ dysfunction and infectious complications in this population.